The stock markets today will eye Q3 results of 81 domestic companies, Flash manufacturing PMI, IPOs, FII selling, and Budget ...

Ascentage Pharma said on Thursday it aims to raise $126.4 million in an initial public offering in the United States, becoming the first sizeable Chinese firm to seek a listing in the U.S. this year.

Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics has now ...

This edition of the Bermuda Public Companies Update summarises significant transactions involving Bermuda companies listed on the New York ...

Rashaun Williams, Atlanta Falcons limited partner and venture capitalist, joined "Closing Bell" on CNBC to discuss his investment strategy and his outlook on the IPO market as 2025 ...

A global biopharma with a U.S. headquarters in Montgomery County is gearing up to go public on a U.S. exchange.

Underwriters have a 30-day option to purchase extra 1.13 million shares from present owners at IPO price. Beta Bionics will not profit monetarily from the sales of this secondary share. Under the ...

Here's the list of options activity happening in today's session: These bullet-by-bullet explanations have been constructed using the accompanying table.

Canadian investors seeking consistent income and exposure to U.S. tech stocks should consider QQCC:CA. Click here to read why QQCC:CA ETF is a Buy.

Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company, today provided an update on the impact of various federal policies in the United States and operations at the ...

UK's digital bank Monzo, one of the nation's most widely-used banking app providers, is gearing up for an Initial Public ...

Northpointe will list on the New York Stock Exchange under the symbol "NPB". It plans to use the IPO proceeds for general corporate purposes, including growing existing lines of business or to redeem ...